Product Description: Abemaciclib metabolite M2 (LSN2839567) is a metabolite of Abemaciclib, acts as a potent CDK4 and CDK6 inhibitor, with IC50s of 1.2 and 1.3 nM, respectively. Anti-cancer activity[1][2].
Applications: Cancer-Kinase/protease
Formula: C25H28F2N8
References: [1]Teresa Burke, et al. Abstract 2830: The major human metabolites of abemaciclib are inhibitors of CDK4 and CDK6. Cancer Research. July 2016, 76 (14)./[2]CHMP. Assessment report Verzenios. 26 July 2018 EMA/551438/2018.
CAS Number: 1231930-57-6
Molecular Weight: 478.54
Compound Purity: 99.94
Research Area: Cancer
Solubility: DMSO : 2 mg/mL (ultrasonic)
Target: CDK;Drug Metabolite